Literature DB >> 26900985

Disseminated tumor cells and dormancy in prostate cancer metastasis.

Emma E van der Toom1, James E Verdone2, Kenneth J Pienta3.   

Abstract

It has been reported that disseminated tumor cells (DTCs) can be found in the majority of prostate cancer (PCa) patients, even at the time of primary treatment with no clinical evidence of metastatic disease. This suggests that these cells escaped the primary tumor early in the disease and exist in a dormant state in distant organs until they develop in some patients as overt metastases. Understanding the mechanisms by which cancer cells exit the primary tumor, survive the circulation, settle in a distant organ, and exist in a quiescent state is critical to understanding tumorigenesis, developing new prognostic assays, and designing new therapeutic modalities to prevent and treat clinical metastases.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26900985      PMCID: PMC4975648          DOI: 10.1016/j.copbio.2016.02.002

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  36 in total

Review 1.  The prostate cancer bone marrow niche: more than just 'fertile soil'.

Authors:  Elisabeth A Pedersen; Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

2.  VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

Authors:  Xin Lu; Euphemia Mu; Yong Wei; Sabine Riethdorf; Qifeng Yang; Min Yuan; Jun Yan; Yuling Hua; Benjamin J Tiede; Xuemin Lu; Bruce G Haffty; Klaus Pantel; Joan Massagué; Yibin Kang
Journal:  Cancer Cell       Date:  2011-12-01       Impact factor: 31.743

3.  Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series.

Authors:  Colm Morrissey; Martine P Roudier; Alex Dowell; Lawrence D True; Melanie Ketchanji; Christopher Welty; Eva Corey; Paul H Lange; Celestia S Higano; Robert L Vessella
Journal:  J Bone Miner Res       Date:  2013-02       Impact factor: 6.741

4.  Homing of cancer cells to the bone.

Authors:  Anjali Mishra; Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Cancer Microenviron       Date:  2011-08-09

5.  Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.

Authors:  Anjali Mishra; Jingcheng Wang; Yusuke Shiozawa; Samantha McGee; Jinkoo Kim; Younghun Jung; Jeena Joseph; Janice E Berry; Aaron Havens; Kenneth J Pienta; Russell S Taichman
Journal:  Mol Cancer Res       Date:  2012-04-19       Impact factor: 5.852

6.  Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow.

Authors:  Yusuke Shiozawa; Elisabeth A Pedersen; Aaron M Havens; Younghun Jung; Anjali Mishra; Jeena Joseph; Jin Koo Kim; Lalit R Patel; Chi Ying; Anne M Ziegler; Michael J Pienta; Junhui Song; Jingcheng Wang; Robert D Loberg; Paul H Krebsbach; Kenneth J Pienta; Russell S Taichman
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

7.  Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence.

Authors:  Todd M Morgan; Paul H Lange; Michael P Porter; Daniel W Lin; William J Ellis; Ian S Gallaher; Robert L Vessella
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

8.  Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients.

Authors:  F Lindemann; G Schlimok; P Dirschedl; J Witte; G Riethmüller
Journal:  Lancet       Date:  1992-09-19       Impact factor: 79.321

9.  In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.

Authors:  Jingli Hao; Michele C Madigan; Aparajita Khatri; Carl A Power; Tzong-Tyng Hung; Julia Beretov; Lei Chang; Weiwei Xiao; Paul J Cozzi; Peter H Graham; John H Kearsley; Yong Li
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

10.  Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.

Authors:  Aya Kobayashi; Hiroshi Okuda; Fei Xing; Puspa R Pandey; Misako Watabe; Shigeru Hirota; Sudha K Pai; Wen Liu; Koji Fukuda; Christopher Chambers; Andrew Wilber; Kounosuke Watabe
Journal:  J Exp Med       Date:  2011-11-28       Impact factor: 14.307

View more
  31 in total

1.  Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment.

Authors:  Rebeca San Martin; Ravi Pathak; Antrix Jain; Sung Yun Jung; Susan G Hilsenbeck; María C Piña-Barba; Andrew G Sikora; Kenneth J Pienta; David R Rowley
Journal:  Cancer Res       Date:  2017-09-15       Impact factor: 12.701

Review 2.  Biochemical Changes in the Niche Following Tumor Cell Invasion.

Authors:  A M Decker; F C Cackowski; Y Jung; R S Taichman
Journal:  J Cell Biochem       Date:  2017-04-18       Impact factor: 4.429

Review 3.  Tumor Dormancy and Slow-Cycling Cancer Cells.

Authors:  John E Davis; Jason Kirk; Yibing Ji; Dean G Tang
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 4.  Genomic and phenotypic heterogeneity in prostate cancer.

Authors:  Michael C Haffner; Wilbert Zwart; Martine P Roudier; Lawrence D True; William G Nelson; Jonathan I Epstein; Angelo M De Marzo; Peter S Nelson; Srinivasan Yegnasubramanian
Journal:  Nat Rev Urol       Date:  2020-12-16       Impact factor: 14.432

Review 5.  Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance.

Authors:  Christine Levesque; Peter S Nelson
Journal:  Cold Spring Harb Perspect Med       Date:  2018-08-01       Impact factor: 6.915

Review 6.  Cancer stem cells in breast and prostate: Fact or fiction?

Authors:  Rocío G Sampayo; Mina J Bissell
Journal:  Adv Cancer Res       Date:  2019-06-13       Impact factor: 6.242

7.  Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis.

Authors:  Lei Li; Jiang-Chao Li; Hong Yang; Xu Zhang; Lu-Lu Liu; Yan Li; Ting-Ting Zeng; Ying-Hui Zhu; Xiao-Dong Li; Yan Li; Dan Xie; Li Fu; Xin-Yuan Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-29       Impact factor: 11.205

Review 8.  Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy.

Authors:  D Brooke Widner; Sun H Park; Matthew R Eber; Yusuke Shiozawa
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

9.  Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy.

Authors:  Chen Qian; Asurayya Worrede-Mahdi; Fei Shen; Anthony DiNatale; Ramanpreet Kaur; Qiang Zhang; Massimo Cristofanilli; Olimpia Meucci; Alessandro Fatatis
Journal:  Mol Cancer Res       Date:  2018-08-16       Impact factor: 5.852

Review 10.  The Cohesive Metastasis Phenotype in Human Prostate Cancer.

Authors:  William L Harryman; James P Hinton; Cynthia P Rubenstein; Parminder Singh; Raymond B Nagle; Sarah J Parker; Beatrice S Knudsen; Anne E Cress
Journal:  Biochim Biophys Acta       Date:  2016-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.